Ticker LaunchIPO · AKAN
Akanda Corp.
Akanda Corp. (AKAN) priced its initial public offering on Mar 16, 2022 at $4.00 per share, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $115.6M. Rimon and Dentons advised the company and Bevilacqua advised the underwriters.
Akanda Corp. is a London-headquartered cannabis cultivation, manufacturing and distribution company. It cultivates and processes cannabis in Lesotho to supply medicinal-grade biomass, flower and concentrates to international wholesalers, and imports and sells medical cannabis products in the United Kingdom.
- Status
- IPO
- Ticker
- AKAN
- Exchange
- Nasdaq Capital Market
- Priced
- Mar 16, 2022
- IPO price
- $4.00
- Market cap at IPO price
- $115.6M
- First filed
- Jan 31, 2022
- Underwriters' counsel
- Bevilacqua
- Sector
- Biotech & pharma
- Country / state
- United Kingdom
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Jan 31, 2022
- Latest amendment Feb 14, 2022
- Final prospectus (424B4) Mar 16, 2022
- All filings on EDGAR CIK 1888014
Other Biotech & pharma IPOs in 2022
- AN2 Therapeutics, Inc.ANTX · Mar 28, 2022 · $69M
- Onconetix, Inc.BWV · Feb 23, 2022 · $20M
- Smart for Life, Inc.SMFL · Feb 17, 2022 · $14.4M
- TC BioPharm (Holdings) plcTCBP · Feb 14, 2022
- Nuvectis Pharma, Inc.NVCT · Feb 7, 2022
- Arcellx, Inc.ACLX · Feb 7, 2022 · $123.8M